Evidence map›Paper›PMID 12890790›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2003

Lack of huntingtin-associated protein-1 causes neuronal death resembling hypothalamic degeneration in Huntington's disease.

Shi-Hua Li, Zhao-Xue Yu, Cui-Lin Li, Huu-Phuc Nguyen, Yong-Xing Zhou, Chuxia Deng, Xiao-Jiang Li

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 72 papers.

0numbers the graph read from it
0cells of the map it votes in
72citing papers in PubMed
3.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

72 citing papers in PubMed, 130 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Huntington's Disease: Complex Pathogenesis and Therapeutic Strategies.International journal of molecular sciences · 2024
    Review
  6. Review
  7. Article
  8. Article
  9. Biological functions and potential therapeutic applications of huntingtin-associated protein 1: progress and prospects.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2022
    Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Loss of Hap1 selectively promotes striatal degeneration in Huntington disease mice.Proceedings of the National Academy of Sciences of the United States of America · 2020
    Article
  17. Article
  18. Article
  19. Article
  20. Article

12 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Shi-Hua LiDepartment of Human Genetics, Emory University School of Medicine, Atlanta, Georgia 30322, USA.
Zhao-Xue Yu
Cui-Lin Li
Huu-Phuc Nguyen
Yong-Xing Zhou
Chuxia Deng
Xiao-Jiang Li
Emory University · USNational Institute of Diabetes and Digestive and Kidney Diseases · USNational Institutes of Health · US

Funding

Neuronal function of huntingtin-associated proteinR01NS036232 · NINDS · EMORY UNIVERSITY · PI ESCAYG, ANDREW P · 1998 to 2021
$6.7M
Synaptic toxicity of Huntington disease proteinR01AG019206 · NIA · EMORY UNIVERSITY · PI LI, XIAO-JIANG · 2001 to 2016
$4.5M
Synaptic accumulation of misfolded proteins and neurodegenerationR56AG019206 · NIA · EMORY UNIVERSITY · PI JIN, PENG · 2018 to 2018
$489k
NIA NIH HHS AG19206NIA NIH HHS R01 AG019206NIA NIH HHS R56 AG019206NINDS NIH HHS NS36232NINDS NIH HHS R01 NS036232
6 · The paper itself

Abstract

Huntington's disease (HD) is caused by a polyglutamine expansion in the disease protein huntingtin. The polyglutamine expansion causes huntingtin to interact abnormally with a number of proteins. However, it is unclear whether, and how, huntingtin-associated proteins are involved in the neurodegeneration in HD. Here, we show that huntingtin-associated protein-1 (HAP1), which is involved in intracellular trafficking of epidermal growth factor receptor (EGFR), is highly expressed in the hypothalamus. Mice lacking HAP1 die after birth because of depressed feeding activity. Terminal deoxynucleotidyl transferase-mediated biotinylated UTP nick end labeling staining and electron microscopic examination revealed the degeneration in hypothalamic regions that control feeding behavior. Hypothalamic degeneration was also observed in HD transgenic mice that have a significant loss of body weight. Inhibition of HAP1 expression decreases EGFR signaling and cell viability, whereas overexpression of HAP1 enhances this signaling activity and inhibits mutant huntingtin-mediated cytotoxicity. These results suggest that the effect of mutant huntingtin on HAP1 and EGFR signaling may contribute to the hypothalamic neurodegeneration and loss of body weight in HD.

Indexed as

AnimalsBody WeightCell DeathCells, CulturedCell SurvivalDisease Models, AnimalDisease ProgressionErbB ReceptorsFeeding BehaviorFetal ViabilityGene TargetingHomozygoteHuntingtin ProteinHuntington DiseaseHypothalamusIn Situ Nick-End LabelingErbB ReceptorsHap1 protein, mouseHap1 protein, ratHtt protein, mouseHtt protein, ratHuntingtin ProteinNerve Tissue ProteinsNuclear Proteins

Identifiers

PMID12890790
PMCPMC6740731
OpenAlexW2150402071

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.